Orna Levran

9PUBLICATIONS
11CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)PharmacogenomicsOptical technologyGene expression (incl. microarray and other genome-wide approaches)Molecular evolution
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Methadone Maintenance Treatment vs. Long-Term Abstinence Without Opioid Agonist: Epigenome-Wide Study of DNA Methylation.

|Mar 27, 2026
Changes in Blood DNA CpG Methylation Levels in Response to Methadone Maintenance Treatment: Epigenome-Wide Longitudinal Study.

Orna Levran, Yuli Kim, Justin Li

|May 25, 2021
OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.

Orna Levran, Matthew Randesi, Miriam Adelson

|Oct 10, 2020
Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis.

Orna Levran, Mary Jeanne Kreek

|Aug 28, 2020
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.

Matthew Randesi, John Rotrosen, Edward V Nunes

|Aug 08, 2020
Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence.

Matthew Randesi, Orna Levran, Wim van den Brink

Pageof 2

Frequent Collaborators

2 joint publications

Matthew Randesi

2 joint publications

Jurg Ott

2 joint publications

Mary Jeanne Kreek

2 joint publications

Einat Peles